Conditions: Intercritical Gout
Keywords: Gout
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 82
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if once-daily treatment with colchicine, compared to placebo, is effective in preventing gout flares in patients who are initiating therapy with allopurinol.

Detailed description:

Arms:
arm 1: daily placebo dosing for 16 weeks with background allopurinol therapy arm 2: daily 0.6 mg colchicine dosing for 16 weeks with background allopurinol therapy

Interventions: intervention 1: Colchicine (Colcrys®) intervention 2: placebo intervention 3: allopurinol
Intervention descriptions: intervention 1: daily 0.6 mg colchicine dosing for 16 weeks intervention 2: daily placebo dosing for 16 weeks intervention 3: background therapy

Protocol document: